This certainly won’t help swallow the  bitter petrol-hike pill. Petrol prices have tripled for the common man in the last 13 years but the country’s top civil servants haven’t had to deal with a fuel hike since 1999. Senior government officials pay a measly Rs. 700 every month to use their air-conditioned official cars for private purposes. This amount was last fixed in 1999, when petrol went for Rs. 23.80...

-The Indian Express Drug regulation is a mess. Everyone who propped up this irresponsible system is to blame Last week, a parliamentary standing committee on health delivered a thoroughly damaging report on the state of drug regulation in India, and the collusion between the regulator, industry and the medical profession that puts patients last. Over 118 pages, it said that the Drug Controller General of India (DCGI) and the Drug Standards Control...

Institutions the bill proposes to set up are not adequately independent of the government The government is reported to be making efforts to seek a consensus amongst its allies and the opposition parties on the Lokpal Bill that is awaiting approval of the Rajya Sabha. People’s movements and some of the main opposition parties have objected to various provisions of the Lokpal and Lokayukta Bill, 2011, as passed in the winter...

Health activists say new policy may not address the weaknesses in ongoing routine immunisation programmes and would flood poor countries with new vaccines When the global health leaders meet in Geneva from May 21 to 26 for the World Health Organization's 65th General Assembly, introducing new vaccines in the low- and middle-income countries would be high on their agenda. A “global draft vaccine action plan”, available on WHO's website, details the implementation...

Health activists from across the country have asked the Union Health and Family Welfare Ministry to take immediate cognisance of the recent report of the Department Related Standing Committee that has criticised the functioning of the Central Drugs Standard Control Organisation (CDSCO) for irregular approvals for clinical trials and sale of medicines to pharmaceutical companies that put patients at risk. In a statement issued here on Wednesday, the activists asked the...